Condition: Colorectal Cancer · Liver Cancer · Gastric Cancer · Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
ACUPOX is a multicenter, open label, 2-cohort based phase II clinical study evaluating the interest of a standardized protocol of verum acupuncture in treatment of Oxaliplatin-induced peripheral neuropathy in patients with gastro-intestinal solid tumors who discontinued oxaliplatin-containing chemotherapy.
This description comes directly from the study's public registry record.
Marie Line GARCIA LARNICOL · 0140298500 · regulatory.affairs@gecor.com.fr
Always discuss trial participation with your own doctor first.
| Centre intercommunal de Créteil | Créteil, France | Not Yet Recruiting |
| Hôpital Henri Mondor | Créteil, France | Recruiting |
| Institu Daniel Hollard | Grenoble, France | Not Yet Recruiting |
| Hôpital Pitié Salpêtrière | Paris, France | Not Yet Recruiting |
| Hôpital Saint Antoine | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05850130